HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027
• The global market for hemostats and sealants is predicted to grow at a CAGR of 8.03% between 2019 and 2027. • The increasing cases of chronic diseases requiring surgeries are primarily driving the global hemostats and sealants market. • The market has been segmented on the basis of its products into topical hemostat and adhesive & tissue sealants. • The synthetic skin sealants sub-segment, under the adhesive & tissue sealants category, is flourishing the most in terms of revenues and was valued at $xx million in 2018.
• The predicted rise in global geriatric population is expected to drive the growth of hemostasis and tissue sealing market over the forecast period in both the developed economies and emerging economies like that of India and China. • The increasing numbers of minimally-invasive cosmetic procedures are expected to propel the number of surgeries in the global healthcare market, which is further expected to propel the market for hemostats and sealants. • Nonetheless, the grafting of the sealants in the body can cause serious medical complications, resulting in their increased scrutiny for safety and effectiveness. This can act as a hurdle for the market to overcome.
“The global hemostats and sealants market is anticipated to grow at a CAGR of 8.03% between 2019 and 2027.�
The hemostasis and tissue sealing a gents market in North America was valued at $ xx million in 2018 and is expected to grow with CAGR of 7.36% over the forecast period.
The Europe hemostats and tissue sealants market is growing at 7.46% CAGR during the forecast period.
The Asia Pacific Hemostats and Tissue Seala nts Market has been estimated to be growing at 9.65% CAGR and is predicted to reach $ xx million by 2027.
Lumenis, Merz Pharma, Depuy Synthes Companies, Cutera, Syneron Medical, Sientra Inc., Sinclair Pharma, Nestle, Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), Cynosure, Inc., Galderma, Alma Lasers Inc., IPSEN, Allergan PLC and Johnson & Johnson are the eminent market players operating in the global market.